Concepedia

Xiangpeng Dai

XD

Statistics

Publications

26

Citations

3.2K

H-Index

22

Active since

2012

Affiliations

Harvard University(Current)

Beth Israel Deaconess Medical Center

Jilin University

Dana-Farber Cancer Institute

Xi'an Jiaotong University

Xiangpeng Dai is an author at Harvard University specializing in molecular biology, molecular oncology, and medicine.

Publications per year

2012–2022

26

Publications

26

Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance

Jinfang Zhang, Xia Bu, Haizhen Wang et al. · Nature · 2017 · 1K citations · Full text

Medicine, Cancer Biology, Oncology +17

Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4

Xiangpeng Dai, Wenjian Gan, Xiaoning Li et al. · Nature Medicine · 2017 · 340 citations · Full text

Medicine, Molecular Biology, Oncology +8

SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression

Wenjian Gan, Xiangpeng Dai, Andrea Lunardi et al. · Molecular Cell · 2015 · 221 citations · Full text

Medicine, Molecular Biology, Oncology +11

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function

Lixin Wan, Kexin Xu, Yongkun Wei et al. · Molecular Cell · 2018 · 196 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +13

TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling

Bin Wang, Zuliang Jie, Donghyun Joo et al. · Nature · 2017 · 192 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

1–5 of 26